Prof. Wang Yang, MD, PhD
Vice Director of Radiation Oncology · Chief Physician of CyberKnife Center, Huashan Hospital · Non-Surgical Neuro-Oncology Specialist
Prof. Wang Yang, MD, PhD
Chief Physician, CyberKnife Radiosurgery Center
-
Hospital AffiliationHuashan Hospital, Fudan Univ.
-
Campus LocationHongqiao CyberKnife & Main Campus
-
Clinical LanguagesEnglish · Mandarin
-
Clinical Practice25+ Years Active Practice
-
Consultation Turnaround24–48 Hours Priority Review
Sub-Millimeter CyberKnife Radiosurgery & Precision Neuro-Radiation Oncology
Prof. Wang Yang, MD, PhD, is Vice Director of the Radiation Oncology Center at Huashan Hospital and Chief Physician at the Huashan CyberKnife Radiosurgery Center. As the institution's foremost expert in non-surgical neuro-oncological management, Prof. Wang directs advanced radiotherapy, stereotactic radiosurgery (SRS/SBRT), and radiosensitizing chemotherapy for primary brain tumors and intracranial metastases.
He completed visiting fellowships at Harvard Medical School's Beth Israel Deaconess Medical Center and Thomas Jefferson University Hospital, mastering advanced fourth-generation CyberKnife robotics. He serves as Vice Chair of the Glioma Radiotherapy Committee of the Chinese Medical Doctor Association and Vice Chair of the Pediatric Neuro-Oncology Committee of CACA. Prof. Wang is renowned for delivering frameless, non-invasive tumor eradication for inoperable deep-seated lesions while preserving neurological, cognitive, and sensory pathways.
Sub-Millimeter Robotic Radiosurgery & Multimodal Tumor Eradication
CyberKnife Robotic Radiosurgery
Real-time tracking and non-isocentric robotic delivery delivering high ablative radiation doses with sub-millimeter precision, free of painful rigid skull stereotactic frames.
Inoperable Brainstem Control
Precision fractionated radiosurgical regimens achieving radical disease control in surgically inaccessible pontine, medullary, and thalamic tumors without neurological deterioration.
Postoperative Adjuvant Radiotherapy
Integrates 3D-conformal IMRT/VMAT protocols with concurrent temozolomide chemotherapy, maximizing local control rates for high-grade glioblastomas and anaplastic tumors.
Brain Metastases & SBRT Ablation
Comprehensive oligometastatic management for lung and breast cancer patients, eradicating intracranial lesions in single or multi-session outpatient stereotactic procedures.
Consultation Sessions & Specialized Clinics
Distinguished Appointments & Radiotherapeutic Leadership
Submit Cranial Records to Prof. Wang Yang's CyberKnife Board
Upload contrast-enhanced cranial MRI/CT DICOM imaging and systemic oncological reports. Prof. Wang's board provides expert stereotactic radiosurgery dosimetry and treatment feasibility assessments within 24 to 48 hours.